Variant report
Variant | nsv964006 |
---|---|
Chromosome Location | chr4:166487853-166491470 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1914833 | chr4:166487927-166487928 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs535345496 | chr4:166487929-166487930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557145801 | chr4:166487930-166487931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575340951 | chr4:166487994-166487995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539933642 | chr4:166488016-166488017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6855033 | chr4:166488036-166488037 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs59397196 | chr4:166488100-166488101 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs377117427 | chr4:166488104-166488105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs180961603 | chr4:166488119-166488120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562048721 | chr4:166488136-166488137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574414147 | chr4:166488197-166488198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10016914 | chr4:166488206-166488207 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs563138953 | chr4:166488214-166488215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185368610 | chr4:166488300-166488301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552251917 | chr4:166488324-166488325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10017098 | chr4:166488400-166488401 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs374891527 | chr4:166488405-166488406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34752855 | chr4:166488407-166488408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555628512 | chr4:166488418-166488419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191518850 | chr4:166488419-166488420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546220743 | chr4:166488432-166488433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541508128 | chr4:166488447-166488448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183306897 | chr4:166488452-166488453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75749224 | chr4:166488509-166488510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572288989 | chr4:166488513-166488514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs67582214 | chr4:166488532-166488533 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs529117923 | chr4:166488533-166488534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139913000 | chr4:166488607-166488608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10017297 | chr4:166488615-166488616 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs533212778 | chr4:166488710-166488711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573411596 | chr4:166488740-166488741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534263927 | chr4:166488747-166488748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373722941 | chr4:166488749-166488750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145348015 | chr4:166488770-166488771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574075082 | chr4:166488781-166488782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147702706 | chr4:166488802-166488803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79713792 | chr4:166488807-166488808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs939078 | chr4:166488875-166488876 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs545237362 | chr4:166488878-166488879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373928379 | chr4:166488954-166488955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570884102 | chr4:166488966-166488967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150507584 | chr4:166488987-166488988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs58023729 | chr4:166488988-166488989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142452070 | chr4:166489023-166489024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78230507 | chr4:166489034-166489035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188703289 | chr4:166489054-166489055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1320227 | chr4:166489134-166489135 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs1320226 | chr4:166489166-166489167 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs142316508 | chr4:166489175-166489176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34552614 | chr4:166489201-166489202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:166485600-166488600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:166488600-166489000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:166489000-166500800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |